Podiatrist, Foot & Ankle Surgery · Miami, FL
NPI
1629249925
Since 2008
Specialty
Podiatrist, Foot & Ankle Surgery
Code 213ES0103X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1190 NW 95th St Ste 401
Miami, FL, 33150
Phone (305) 835-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$365K
3,779 services
Medicare patients, 2024
188
Average age 71
Drug cost, 2024
$158K
2,599 prescriptions
Company payments, 2025
$1,513
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Imaze M Davis was code 87798 (infectious agent detection by dna/rna), 923 times for 41 patients. In total Imaze M Davis billed 3,779 services in 101 codes, and Medicare paid $365K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 87798 Infectious Agent Detection by DNA/RNA | Office | 923 | 41 | $34.39 | $32K |
| 99213 Office E&M - Established | Office | 376 | 111 | $76.89 | $29K |
| 11765 Nail Procedure | Office | 222 | 52 | $104.70 | $23K |
| 99232 Hospital E&M - Subsequent | Facility | 210 | 40 | $70.89 | $15K |
| 11755 Nail Procedure | Office | 123 | 67 | $75.80 | $9,323 |
| 99214 Office E&M - Established | Office | 99 | 40 | $114.65 | $11K |
| 29581 Musculoskeletal | Office | 98 | 16 | $67.66 | $6,631 |
| 11721 Nail Procedure | Office | 96 | 51 | $37.96 | $3,644 |
| 11056 Removal or Shaving of Skin Growth | Office | 86 | 32 | $45.85 | $3,943 |
| 73630 X-ray - Lower Extremity | Office | 83 | 38 | $28.30 | $2,349 |
| 87481 Infectious Agent Detection by DNA/RNA | Office | 80 | 19 | $34.39 | $2,751 |
| 17110 Destruction Skin Lesion | Office | 75 | 24 | $80.19 | $6,014 |
| 11000 Debridement | Office | 65 | 29 | $30.06 | $1,954 |
| 97597 Debridement | Office | 60 | 24 | $84.91 | $5,094 |
| 11042 Debridement | Office | 56 | 23 | $93.66 | $5,245 |
By year: 2022 $300K for 3,967 services; 2023 $200K for 2,941 services; 2024 $365K for 3,779 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87798 Infectious Agent Detection by DNA/RNA | 923 | 41 | $34.39 | $32K |
| 87481 Infectious Agent Detection by DNA/RNA | 80 | 19 | $34.39 | $2,751 |
| 87500 Infectious Agent Detection by DNA/RNA | 52 | 26 | $34.39 | $1,788 |
| 87640 Infectious Agent Detection by DNA/RNA | 52 | 26 | $34.39 | $1,788 |
| 87641 Infectious Agent Detection by DNA/RNA | 52 | 26 | $34.39 | $1,788 |
| 87651 Infectious Agent Detection by DNA/RNA | 52 | 26 | $34.39 | $1,788 |
Medicare prescription drug claims, 2024
In 2024, the drug Imaze M Davis prescribed most often to Medicare patients was Ammonium Lactate, with 633 prescriptions and refills. In total Imaze M Davis wrote 2,599 Medicare prescriptions that cost $158K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ammonium Lactate Generic | 633 | 739 | 311 | $18K |
| Clotrimazole Generic | 617 | 797 | 295 | $40K |
| Ketoconazole Generic | 477 | 577 | 247 | $9,024 |
| Mupirocin Generic | 121 | 130 | 92 | $1,042 |
| Lidocaine Generic | 94 | 103 | 50 | $2,979 |
| Cephalexin Generic | 87 | 87 | 80 | $1,236 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 85 | 108 | 55 | $2,999 |
| Ciclopirox Generic | 73 | 82 | 37 | $2,121 |
| Diclofenac Sodium Generic | 67 | 74 | 31 | $1,368 |
| Doxycycline Hyclate Generic | 60 | 60 | 51 | $577 |
| Meloxicam Generic | 34 | 37 | 31 | $52.53 |
| Santyl Collagenase Clostridium Hist. | 34 | 38 | 26 | $49K |
| Ciprofloxacin Hcl Generic | 27 | 27 | 21 | $181 |
| Ibuprofen Generic | 22 | 22 | 19 | $112 |
| Gabapentin Generic | 21 | 25 | 12 | $169 |
Brand drugs: 44 claims; generic drugs: 2,555 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Imaze M Davis $1,513 ($1,513 in general payments such as food, travel and fees) from 17 companies. The largest payer was Aroa Biosurgery Incorporated with $319.
| Company | Payments | Amount |
|---|---|---|
| Aroa Biosurgery Incorporated ARX.AX | 9 | $319 |
| Innovation Technologies Inc | 1 | $199 |
| Paratek Pharmaceuticals, Inc. | 3 | $154 |
| Medtronic, Inc. MDT | 2 | $142 |
| Stryker Corporation SYK | 2 | $126 |
| AngioDynamics, Inc. ANGO | 1 | $121 |
| Bioventus LLC BVS | 1 | $117 |
| Smith+Nephew, Inc. SNN | 3 | $75.83 |
| Amgen Inc. AMGN | 2 | $67.05 |
| BioWound Solutions, Inc. | 1 | $43.55 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.